Print

FEATURED NEWS

Results: 68 Articles found.
  • Analysis of Specialty Distributors Reveals Continued Growth
    December 13, 2019

    A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4 percent.

  • Pharmaceutical Sales Through Primary Distributors Reach $493 Billion
    December 6, 2019

    In 2018, sales through pharmaceutical distributors increased by 6.7 percent, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for 44.6 percent of all sales, a slight increase from 2017. Distributor margins, however, continued a four-year slide, though they showed increases in efficiency.

  • HDA Statement on Proposed DEA Regulations
    October 28, 2019

    In response to the Drug Enforcement Administration’s (DEA) proposed regulations related to the review and monitoring of annual production quotas, the Healthcare Distribution Alliance (HDA) released the following statement.

  • Drew and Mauch Reelected to Lead HDA Board of Directors
    October 21, 2019

    The Healthcare Distribution Alliance (HDA) announced that Greg Drew, RPh, President of Value Drug Company, and Robert Mauch, PhD, PharmD, EVP and Group President of AmerisourceBergen Corporation, were recently elected to second terms as Chairman and Vice Chairman of the HDA Board of Directors.

  • Key Excerpts from IG Review of the DEA's Efforts to Control the Diversion of Opioids
    October 1, 2019

    The following are excerpts from the recent report by the Office of the Inspector General, U.S. Department of Justice on the Drug Enforcement Administration’s (DEA) regulatory and enforcement efforts to control the diversion of opioids.

© 2019 Healthcare Distribution Alliance. All rights reserved.